Last updated: May 11, 2024
Sponsor: Wunschbaby Institut Feichtinger
Overall Status: Active - Recruiting
Phase
N/A
Condition
In Vitro Fertilization
Treatment
Propofol
Clinical Study ID
NCT05741814
518-2022
Ages 18-40 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient undergoing first oocyte pickup Understands german language to fill out questionnaire
Exclusion
Exclusion Criteria:
BMI >30 BMI <17 Heavy endometriosis Patients undergoing a consecutive IVF attempt
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: Propofol
Phase:
Study Start date:
May 05, 2022
Estimated Completion Date:
December 31, 2024
Connect with a study center
Wunschbaby Institut Feichtinger
Vienna, 1130
AustriaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.